Skip to main content
Clinical Trials/NCT04779918
NCT04779918
Recruiting
Not Applicable

A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix

Tela Bio Inc10 sites in 1 country160 target enrollmentApril 29, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hernia, Ventral
Sponsor
Tela Bio Inc
Enrollment
160
Locations
10
Primary Endpoint
Early surgical site occurrences or wound related events
Status
Recruiting
Last Updated
6 months ago

Overview

Brief Summary

This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.

Detailed Description

This study is intended to evaluate the post-operative complications and recurrence following the use of OviTex in ventral or inguinal hernias being treated robotically. It is a single-arm study and all subjects will receive OviTex.

Registry
clinicaltrials.gov
Start Date
April 29, 2021
End Date
December 30, 2027
Last Updated
6 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject suffers from a ventral or inguinal hernia that requires surgical repair with the use of an implant to reinforce or replace weakened or missing tissue.
  • The patient is scheduled for an elective robotic approach with the use of OviTex LPR, OviTex Core Permanent, or OviTex 1S Permanent.
  • The size of the implant needed for repair is expected to be less than or equal to 15 x 25 cm for OviTex LPR and 25 x 40 cm for OviTex Core Permanent and OviTex 1S Permanent.
  • Subject meets CDC/SSI Wound Classification Class I (Clean), Class II (Clean-Contaminated) or Class III (Contaminated) criteria.
  • Subject is willing and able to sign an informed consent for the study and has signed the IRB approved Informed Consent form for this study.
  • Subject is able to complete Quality of Life (QoL) and pain questionnaires.
  • Subject is at least 21 years old.
  • Subject is willing to comply and able to participate fully in, and for the full duration of, the study including follow-up requirements.
  • Exclusion Criteria at Baseline:
  • Subject has a BMI of \> 40

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Early surgical site occurrences or wound related events

Time Frame: occurring within the first 3 months of the ventral or inguinal hernia repair

Incidence of early peri- and post-operative surgical site occurrences or wound related events noted at the hernia repair site

Early post-operative complications

Time Frame: occurring within the first 3 months of the ventral or inguinal hernia repair.

Incidence of other early post-operative complications

Secondary Outcomes

  • Late surgical site occurrences or wound related events(occurring > 3 months after index surgery)
  • Patient Reported Outcomes(Assessed at day 30, day 90, 12 months, and 24 months post-op)
  • Late post-operative complications(occurring > 3 months after index surgery.)
  • Hernia Recurrence(at post-operative day 90 and months 12 and 24)

Study Sites (10)

Loading locations...

Similar Trials